Cellectricon Launches World’s First System for High Throughput RNAi Screening

Cellectricon has announced the launch of the new Cellaxess® HT System. According to company, Cellaxess® HT is world’s first fully automated high throughput transfection system that can enable reagent-free delivery of genetic material to a wide range of biologically relevant cell types.

The system will be introduced at the SBS 14th Annual Conference and Meeting in St. Louis, MO, USA, April 6-10.

Cellectricon has developed Cellaxess® HT in close collaboration with research groups to meet the increasing demand for a technology capable of genome-wide RNAi screening.

"We are very pleased to meet the industry’s demand by bringing this state-of-the-art system to the market.” says Dr. Mattias Karlsson, CEO of Cellectricon. “Cellaxess ® HT will revolutionize target discovery by opening the door to using more biologically relevant cell types in genome-wide RNAi screening.”